PAD 112 (Moexipril 15 mg)
Pill imprint PAD 112 has been identified as Moexipril hydrochloride 15 mg.
Moexipril is used in the treatment of left ventricular dysfunction; high blood pressure; heart failure; heart attack; diabetic kidney disease and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy. Moexipril 15 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for PAD 112 (Moexipril 15 mg)
- Imprint:
-
PAD 112
- Strength:
- 15 mg
- Color:
- Beige
- Size:
- 8.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Angiotensin converting enzyme inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Paddock Laboratories, Inc.
- National Drug Code (NDC):
- 00574-0112
- Inactive Ingredients:
- lactose monohydrate
crospovidone
magnesium oxide
povidone
silicon dioxide
magnesium stearate
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54569-5916 | A S Medication Solutions LLC (repackager) |
Note: Inactive ingredients may vary.
More resources
Moexipril hydrochloride is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...
